Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVITIUM PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 27

FDA approve MESALAMINE

Comment Full text

ALEMBIC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 25

FDA approve CARBAMAZEPINE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 20

FDA approve ABACAVIR SULFATE; LAMIVUDINE

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 26

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 20

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 16

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 18

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

RUBICON

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 20

FDA approve GUANFACINE HYDROCHLORIDE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 20

FDA approve MONTELUKAST SODIUM

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 22

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text
  • Previous
  • 94
  • 95
  • 96
  • 97
  • 98
  • Next

Search

News categories

  • Technical Exchange News(9827)
  • Event(407)
  • SEC News(165210)
  • FDA Approval(9288)
  • Company Report(721)
  • Business News(110603)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin